Patents by Inventor Mark Dennis

Mark Dennis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260146088
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 2, 2025
    Publication date: May 28, 2026
    Applicant: Genentech, Inc.
    Inventors: Yvonne CHEN, Mark DENNIS, David DORNAN, Kristi ELKINS, Jagath Reddy JUNUTULA, Andrew POLSON, Bing ZHENG
  • Patent number: 12583937
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: March 24, 2026
    Assignee: Genentech, Inc.
    Inventors: Mark Dennis, Bonnee Rubinfeld, Paul Polakis
  • Patent number: 12492263
    Abstract: The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: December 9, 2025
    Assignee: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Jagath Reddy Junutula, Gail Lewis Phillips, Thomas Harden Pillow, Mark X. Sliwkowski
  • Publication number: 20250333723
    Abstract: The invention provides an expression and secretion system, and methods of using the same, for the expression and secretion of one fusion protein in prokaryotic cells and a second fusion protein in eukaryotic cells. Also provided herein are nucleic acid molecules, vectors and host cells comprising such vectors and nucleic acid molecules.
    Type: Application
    Filed: February 26, 2025
    Publication date: October 30, 2025
    Inventors: Devin TESAR, Xiaocheng CHEN, Mark DENNIS, Isidro HOTZEL
  • Patent number: 12260383
    Abstract: An exemplary system includes at least one physical computing device that is communicatively coupled, by way of a network, to an automated teller machine (ATM), and that receives, by way of user input to the ATM, a transaction identifier, verifies that the transaction identifier represents, in an electronic payment system, an electronic payment of an amount from a sender to a recipient by way of the electronic payment system, generates an access code for the electronic payment, initiates a transmission of the access code to a computing device of the recipient, receives, by way of additional user input to the ATM, the access code for the electronic payment, validates the received access code for the electronic payment, and directs, in response to the validation of the received access code, the ATM to disburse the amount of the electronic payment in physical currency.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: March 25, 2025
    Assignee: PNC Global Transfers, Inc.
    Inventors: Mark Dennis, Miguel Angel Macias, Jaime Caballero
  • Publication number: 20240368306
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Application
    Filed: February 13, 2024
    Publication date: November 7, 2024
    Inventors: Xiaocheng CHEN, Mark Dennis, Janet Jackman, James T. Koerber, Mason Lu, Henry R. Maun, Kathila Rajapaksa, Saroja Ramanujan, Tracy Staton, Lawren Wu, Tangsheng Yi
  • Publication number: 20240309088
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 21, 2023
    Publication date: September 19, 2024
    Applicant: Genentech, Inc.
    Inventors: Yvonne CHEN, Mark DENNIS, David DORNAN, Kristi ELKINS, Jagath Reddy JUNUTULA, Andrew POLSON, Bing ZHENG
  • Patent number: 11939396
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 26, 2024
    Assignee: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Janet Jackman, James T. Koerber, Mason Lu, Henry R. Maun, Kathila Rajapaksa, Saroja Ramanujan, Tracy Staton, Lawren Wu, Tangsheng Yi
  • Publication number: 20240043831
    Abstract: The invention provides an expression and secretion system, and methods of using the same, for the expression and secretion of one fusion protein in prokaryotic cells and a second fusion protein in eukaryotic cells. Also provided herein are nucleic acid molecules, vectors and host cells comprising such vectors and nucleic acid molecules.
    Type: Application
    Filed: March 10, 2023
    Publication date: February 8, 2024
    Inventors: Devin TESAR, Xiaocheng CHEN, Mark DENNIS, Isidro HOTZEL
  • Patent number: 11866496
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: January 9, 2024
    Assignee: Genentech, Inc.
    Inventors: Yvonne Chen, Mark Dennis, Kristi Elkins, Jagath Reddy Junutula, Andrew Polson, Bing Zheng
  • Publication number: 20230041134
    Abstract: The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: April 14, 2022
    Publication date: February 9, 2023
    Applicant: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Jagath Reddy Junutula, Gail Lewis Phillips, Thomas Harden Pillow, Mark X. Sliwkowski
  • Publication number: 20220251197
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: April 20, 2022
    Publication date: August 11, 2022
    Applicant: Genentech, Inc.
    Inventors: Yvonne CHEN, Mark DENNIS, David DORNAN, Kristi ELKINS, Jagat Reddy JUNUTULA, Andrew POLSON, Bing ZHENG
  • Publication number: 20220204640
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 30, 2022
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Bonnee Rubinfeld, Paul Polakis
  • Publication number: 20220164781
    Abstract: An exemplary system includes at least one physical computing device that is communicatively coupled, by way of a network, to an automated teller machine (ATM), and that receives, by way of user input to the ATM, a transaction identifier, verifies that the transaction identifier represents, in an electronic payment system, an electronic payment of an amount from a sender to a recipient by way of the electronic payment system, generates an access code for the electronic payment, initiates a transmission of the access code to a computing device of the recipient, receives, by way of additional user input to the ATM, the access code for the electronic payment, validates the received access code for the electronic payment, and directs, in response to the validation of the received access code, the ATM to disburse the amount of the electronic payment in physical currency.
    Type: Application
    Filed: February 14, 2022
    Publication date: May 26, 2022
    Inventors: Mark Dennis, Miguel Angel Macias, Jaime Caballero
  • Patent number: 11315092
    Abstract: An exemplary system includes at least one physical computing device that is communicatively coupled, by way of a network, to an automated teller machine (ATM), and that receives a transaction identifier from the ATM, uses the transaction identifier to query an electronic payment system, receives, from the electronic payment system in response to the query, data representative of a pending electronic payment that is associated with the transaction identifier and is awaiting funding, sends data representative of information about the pending electronic payment to the ATM, the information indicating an amount to fund the pending electronic payment, receives, from the ATM, a confirmation that the ATM has received the amount to fund the pending electronic payment, and notifies the electronic payment system that the pending electronic payment has been funded.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: April 26, 2022
    Assignee: PNC Global Transfers, Inc.
    Inventors: Mark Dennis, Miguel Angel Macias, Jaime Caballero
  • Patent number: 11282053
    Abstract: An exemplary system includes at least one physical computing device that is communicatively coupled, by way of a network, to an automated teller machine (ATM), and that receives, by way of user input to the ATM, a transaction identifier, verifies that the transaction identifier represents, in an electronic payment system, an electronic payment of an amount from a sender to a recipient by way of the electronic payment system, generates an access code for the electronic payment, initiates a transmission of the access code to a computing device of the recipient, receives, by way of additional user input to the ATM, the access code for the electronic payment, validates the received access code for the electronic payment, and directs, in response to the validation of the received access code, the ATM to disburse the amount of the electronic payment in physical currency.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: March 22, 2022
    Assignee: PNC Global Transfers, Inc.
    Inventors: Mark Dennis, Miguel Angel Macias, Jaime Caballero
  • Publication number: 20220023437
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: April 19, 2021
    Publication date: January 27, 2022
    Applicant: Genentech, Inc.
    Inventors: Yvonne CHEN, Mark DENNIS, Kristi ELKINS, Jagath Reddy JUNUTULA, Andrew POLSON, Bing ZHENG
  • Patent number: 11167038
    Abstract: The present invention relates to compositions and methods for improving the safety of blood-brain barrier receptor-mediated blood-brain barrier transport.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: November 9, 2021
    Assignee: Genentech, Inc.
    Inventors: Ryan Jefferson Watts, Joy Yu Zuchero, Jessica Couch, Mark Dennis
  • Patent number: 11144901
    Abstract: An exemplary system includes at least one physical computing device that is communicatively coupled, by way of a network, to a retail point of sale (POS) machine, and that receives a transaction identifier from the POS machine, uses the transaction identifier to query an electronic payment system, receives, from the electronic payment system in response to the query, data representative of a pending electronic payment that is associated with the transaction identifier and is awaiting funding, sends data representative of information about the pending electronic payment to the POS machine, the information indicating an amount to fund the pending electronic payment, receives, from the POS machine, a confirmation that the POS machine has received the amount to fund the pending electronic payment, and notifies the electronic payment system that the pending electronic payment has been funded.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: October 12, 2021
    Assignee: BBVA Transfer Services, Inc.
    Inventors: Mark Dennis, Miguel Angel Macias, Jaime Caballero
  • Publication number: 20210292440
    Abstract: The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.
    Type: Application
    Filed: January 28, 2021
    Publication date: September 23, 2021
    Applicant: Genentech, Inc.
    Inventors: Mark Dennis, Ryan Jefferson Watts, Yunhua Yu Zuchero, Yin Zhang